Exercise during pregnancy. Activity, aerobic and step exercise
Conditions
Interventions
Intervention 1: Intervention group1 (supervised exercise): the women will exercise three 30-60 min sessions per week from 12-18th to 38th week of gestational age, adapted to the pregnancy trimesters.
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Pregnant women in the 12th-18th weeks of pregnancy 1st to 3rd pregnancy Aged 18-40 years Having a singleton fetus with no known malformation No previous history of cesarean section No previous history of premature labour Be literate Iranian nationality of wife and husband
Exclusion criteria
Exclusion criteria: Abnormal (unicorn / septum) uterus Incompetent cervix Cardiovascular or respiratory diseases Uncontrolled type I diabetes Chronic hypertension Symptomatic anemia Uncontrolled thyroid disease Shortness of breath before exercise and chest pain Orthopedic limitations Regular aerobic exercise longer than 30 minutes twice a week or more, during current pregnancy BMI > 35 Having suicidal thoughts Unwillingness or inability to attend exercise sessions regularly Severe back pain
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compliance rate of the aerobic exercises during pregnancy (average number and duration of exercise in a week). Timepoint: Two times (1- during 12-18 to 26-28, 2- during 26-28 to 36-38 weeks of pregnancy). Method of measurement: a diary form.;Depression Score. Timepoint: At baseline, 26-28 weeks of pregnancy, and 6-8 weeks after delivery. Method of measurement: Edinburgh Depression questionnaire.;Positive and negative affect Score. Timepoint: At baseline, 26-28 ?36-38 weeks of pregnancy, and 6-8 weeks after delivery. Method of measurement: Positive and Negative Affect Scale (PANAS).;Birth weight. Timepoint: After delivery. Method of measurement: Hospital record. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety score. Timepoint: At baseline, 26-28 weeks of pregnancy and 6 months after delivery. Method of measurement: Anxiety section of the Depression, Anxiety and Stress Scale (DASS-21).;Well-Being Score. Timepoint: At baseline, 26-28 & 36-38 weeks of pregnancy and 6-8 weeks after delivery. Method of measurement: World Health Organization-Five Well-being Index.;Fatigue score. Timepoint: At baseline, 26-28 weeks of pregnancy, 6-8 weeks and 6 months after delivery. Method of measurement: Multidimensional Assessment of Fatigue scale.;Sexual function Score. Timepoint: At baseline, 26-28 weeks of pregnancy and 6 months after delivery. Method of measurement: Female sexual function questionnaire (FSFI).;Low back pain score. Timepoint: At baseline, 26-38 & 36-38 weeks of pregnancy and 6-8 weeks and 6 months after delivery. Method of measurement: Visual analogue scale (VAS).;Urgent and stress urinary incontinence Score. Timepoint: At baseline, 26-28 & 36-38 weeks of pregnancy and 6-8 weeks & 6 months after delivery. Method of measurement: Urinary Incontinence Diagnosis Questionnaire.;Pregnancy weight gain. Timepoint: During pregnancy. Method of measurement: Using Prenatal record.;Gestational age. Timepoint: At Birth. Method of measurement: Using date of last menstrual period or ultrasound report and birth date.;Fear of childbirth. Timepoint: 36-38 weeks of pregnancy. Method of measurement: Wijma Delivery Expectancy (W-DEQ).;Score of birth satisfaction. Timepoint: 6-8 weeks after delivery. Method of measurement: Iranian version of birth satisfaction scale-revised.;Occurrence of Pregnancy complications (gestational hypertension or pre-eclampsia, gestational diabetes). Timepoint: 26-28 weeks and 36-38 weeks of pregnancy. Method of measurement: Prenatal record.;Premature or preterm delivery. Timepoint: After delivery. Method of measurement: Using date of last menstrual period or ultrasound report and birth date.;Cesarean section. Timepoint: After delivery. Method of measurement | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfsaneh veisy
Tabriz University of Medical Sciences
Outcome results
None listed